An emerging body of data suggest that aberrant activation of the CaMKK2-AMPK pathway may be involved in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, the most common form of dementia [52]. Here, CAMKK2 is linked to Alzheimer disease.